![Making Complete Genome Sequencing Affordable, Accessible](https://www.g2intelligence.com/wp-content/uploads/2023/06/July23.DTET_.Verkko-iStock-1344985871_1100x800-1080x675.jpg)
Making Complete Genome Sequencing Affordable, Accessible
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Lab industry insiders say they’re confident the Saving Access to Laboratory Services Act (SALSA) will pass in 2023.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
According to a recent report, Medicare overpaid for such services over a two-year period between 2019 and 2020.
Current genetic testing enforcement trends and what you can do to minimize the liability risks of your lab.
After it failed to pass at the end of 2022, lab leaders and other insiders say they’re optimistic SALSA will pass this year.
Gather Labs founder and CEO Rachael McCrary discusses how her lab has achieved success beyond COVID-19 testing.